|
Erickson, Yasuko O; Samia, Noelle I; Bedell, Bruce et al. (2009) Elevated procalcitonin and C-reactive protein as potential biomarkers of sepsis in a subpopulation of thrombotic microangiopathy patients. J Clin Apher 24:150-4
|
|
Raife, Thomas J; Cao, Wenjing; Atkinson, Bonnie S et al. (2009) Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site. Blood 114:1666-74
|
|
Mosesson, M W; Hernandez, I; Raife, T J et al. (2007) Plasma fibrinogen gamma'chain content in the thrombotic microangiopathy syndrome. J Thromb Haemost 5:62-9
|
|
Raife, Thomas J; Friedman, Kenneth D; Dwyre, Denis M (2006) The pathogenicity of von Willebrand factor in thrombotic thrombocytopenic purpura: reconsideration of treatment with cryopoor plasma. Transfusion 46:74-9
|
|
Raife, Thomas; Friedman, Kenneth D; Fenwick, Brad (2004) Lepirudin prevents lethal effects of Shiga toxin in a canine model. Thromb Haemost 92:387-93
|
|
Raife, Thomas; Atkinson, Bonnie; Montgomery, Robert et al. (2004) Severe deficiency of VWF-cleaving protease (ADAMTS13) activity defines a distinct population of thrombotic microangiopathy patients. Transfusion 44:146-50
|
|
Mauro, Michael; Zlatopolskiy, Andrey; Raife, Thomas J et al. (2004) Thienopyridine-linked thrombotic microangiopathy: association with endothelial cell apoptosis and activation of MAP kinase signalling cascades. Br J Haematol 124:200-10
|
|
Raife, Thomas J; Lentz, Steven R; Atkinson, Bonnie S et al. (2002) Factor V Leiden: a genetic risk factor for thrombotic microangiopathy in patients with normal von Willebrand factor-cleaving protease activity. Blood 99:437-42
|
|
Raife, T; Montgomery, R (2001) New aspects in the pathogenesis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Rev Clin Exp Hematol 5:236-61; discussion 311-2
|
|
Raife, T J; Montgomery, R R (2000) von Willebrand factor and thrombotic thrombocytopenic purpura. Curr Opin Hematol 7:278-83
|
Showing the most recent 10 out of 11 publications
